Docusign Inc. $DOCU Stake Cut by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. cut its holdings in shares of Docusign Inc. (NASDAQ:DOCU) by 42.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 214,345 shares of the company’s stock after selling 158,142 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Docusign were worth $15,452,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. State Street Corp boosted its stake in shares of Docusign by 3.0% during the 2nd quarter. State Street Corp now owns 8,074,976 shares of the company’s stock valued at $628,960,000 after buying an additional 236,494 shares during the period. American Century Companies Inc. increased its stake in shares of Docusign by 1.6% in the second quarter. American Century Companies Inc. now owns 5,564,318 shares of the company’s stock worth $433,405,000 after acquiring an additional 86,560 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Docusign by 1.5% during the second quarter. Geode Capital Management LLC now owns 3,985,808 shares of the company’s stock worth $309,910,000 after acquiring an additional 59,941 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Docusign by 18.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,028,505 shares of the company’s stock valued at $165,120,000 after purchasing an additional 318,698 shares during the last quarter. Finally, Norges Bank purchased a new position in Docusign in the second quarter valued at about $140,987,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insider Buying and Selling

In other news, Director James A. Beer sold 450 shares of the firm’s stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $68.54, for a total value of $30,843.00. Following the sale, the director owned 14,478 shares in the company, valued at approximately $992,322.12. This trade represents a 3.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider James P. Shaughnessy sold 12,000 shares of the business’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $67.03, for a total transaction of $804,360.00. Following the transaction, the insider directly owned 54,550 shares in the company, valued at $3,656,486.50. This trade represents a 18.03% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 45,542 shares of company stock worth $3,092,260. 1.01% of the stock is currently owned by company insiders.

Docusign Stock Performance

Shares of NASDAQ:DOCU opened at $69.80 on Friday. The stock’s 50-day moving average is $68.52 and its 200-day moving average is $72.97. The company has a market cap of $13.98 billion, a P/E ratio of 48.81, a P/E/G ratio of 3.43 and a beta of 0.99. Docusign Inc. has a 52-week low of $63.41 and a 52-week high of $99.30.

Analyst Ratings Changes

A number of equities analysts recently commented on DOCU shares. JPMorgan Chase & Co. dropped their price objective on Docusign from $80.00 to $78.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Robert W. Baird dropped their price target on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. BTIG Research began coverage on shares of Docusign in a report on Tuesday, December 16th. They set a “buy” rating and a $88.00 price target on the stock. JMP Securities restated a “market outperform” rating and set a $124.00 target price on shares of Docusign in a report on Friday, October 3rd. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Docusign in a research report on Wednesday, October 8th. Six research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $85.13.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.